This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Carl C. Bartels, M.D.; James A. Evans, M.D.; Robert G. Townley, M.D.

J Am Med Assoc. 1959;170(15):1796-1802.

Abstract
A definite hypotensive effect from chlorothiazide was observed in 80 % of 65 patients studied. This was more pronounced in those with severe hypertension and in those receiving ganglionic blocking agents. Of the 23 patients who had formerly required ganglionic blocking agents, 12 were able to discontinue that therapy. It would seem that periodic determinations of the serum potassium level are necessary in any patient who is receiving chlorothiazide on a long-term basis. Twenty-eight patients (43%) in this group showed a drop in potassium level to 3.5 mEq. per liter or below. This occurred in 12 despite the concurrent administration of 2 to 3 Gm. of potassium chloride daily. It is now well recognized that renal lesions may accompany potassium deficiency in man. Symptoms of this may be minimal and their onset insidious. There is also danger of hypokalemia potentiating digitalis poisoning.

Author Affiliations
Boston

From the Department of Internal Medicine, Lahey Clinic.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Intravenously Administered Chlorothiazide in Diagnostic Evaluation of Hypertensive Disease
McGuffin and Gunnells
Arch Intern Med 1969;123:124-130.
ABSTRACT  

Commentary on Incidence of Primary Aldosteronism: Current Estimations Based on Objective Data
Kaplan
Arch Intern Med 1969;123:152-154.
ABSTRACT